A tragic triad: Coronary artery disease, nicotine addiction, and depression

Current Opinion in Cardiology

Volumn 24, Issue 5, 2009, Pages 447-453

  Thorndike, Anne N ^a   Rigotti, Nancy A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cardiovascular disease; Depression; Hospitalization; Smoking cessation

Indexed keywords

AMFEBUTAMONE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANTIDEPRESSANT AGENT; NICOTINE; NORTRIPTYLINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; VARENICLINE; VENLAFAXINE;

BECK DEPRESSION INVENTORY; BEHAVIOR CHANGE; BRAIN LEVEL; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FOLLOW UP; GENETIC PREDISPOSITION; HERITABILITY; HUMAN; IMMOBILIZATION; MAJOR DEPRESSION; NEUROTRANSMITTER RELEASE; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT COUNSELING; PREVALENCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RELAPSE; REVIEW; RISK REDUCTION; SCREENING; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT OUTCOME; WITHDRAWAL SYNDROME; COMPLICATION; GENETICS; RISK FACTOR; SYNDROME; TOBACCO USE DISORDER; UNITED STATES;

CORONARY ARTERY DISEASE; DEPRESSION; HUMANS; NICOTINE; PREVALENCE; RISK FACTORS; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; SYNDROME; TOBACCO USE DISORDER; UNITED STATES;

EID: 69749116530     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32832ed645     Document Type: Review

References (56)

1. Merz CN, Rozanski A, Forrester JS. The secondary prevention of coronary artery disease. Am J Med 1997; 102:572-581. (Pubitemid 27305121)
2. Rea TD, Heckbert SR, Kaplan RC, et al. Smoking status and risk for recurrent coronary events after myocardial infarction. Ann Intern Med 2002; 137:494-500. (Pubitemid 35024620)
3. Smaha LA. The American Heart Association Get With The Guidelines program. Am Heart J 2004; 148 (5 Suppl):S46-S48. (Pubitemid 39425040)
4. Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation 2006; 113:2363-2372.
5. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 2003; 290:86-97. (Pubitemid 37432870)
6. Fiore MC, Jaen CR, Baker TB, et al. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Rockville, Maryland: US Department of Health and Human Services. Public Health Service. May 2008. An update of clinical practice guidelines for treating smoking cessation based on the most recent scientific evidence and expert clinical judgment.
7. The Joint Commission. National Hospital Quality Measures/The Joint Commission Core Measures. http://www.jointcommission.org/NR/rdonlyres/A929F4B9- 4F77-4983-9D9A-8661FDE01F1B/0/oryx-hap-cm-list.pdf. [Accessed 4 April 2009]
8. Thomas RJ, King M, Lui K, et al. AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services. Circulation 2007; 116:1611-1642. (Pubitemid 47511427)
9. Taylor CB, Houston-Miller N, Killen JD, DeBusk RF. Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention. Ann Intern Med 1990; 113:118-123. (Pubitemid 20218629)
10. Dornelas EA, Sampson RA, Gray JF, et al. A randomized controlled trial of smoking cessation counseling after myocardial infarction. Prev Med 2000; 30:261-268. (Pubitemid 30211083)
11. Quist-Paulsen P, Gallefoss F. Randomised controlled trial of smoking cessation intervention after admission for coronary heart disease. BMJ 2003; 327:1254-1257. (Pubitemid 37487281)
12. Thorndike AN, Regan S, McKool K, et al. Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease. Arch Intern Med 2008; 168:186-191. This is the first study to demonstrate that moderate depressive symptoms measured during hospitalization for CVD predict early relapse to smoking after discharge and lower rates of validated smoking cessation at 1-year follow-up. Higher withdrawal symptoms in depressed smokers partially mediated the relationship between depression and relapse. (Pubitemid 351185886)
13. Perez GH, Nicolau JC, Romano BW, Laranjeira R. Depression: a predictor of smoking relapse in a 6-month follow-up after hospitalization for acute coronary syndrome. Eur J Cardiovasc Prev Rehabil 2008; 15:89-94. This study showed that current depression measured during hospitalization for MI or unstable angina predicted relapse to smoking by self-report at 6 months. (Pubitemid 351263261)
14. Dawood N, Vaccarino V, Reid KJ, et al., for the PREMIER Registry Investigators. Predictors of smoking cessation after a myocardial infarction: the role of institutional smoking cessation programs in improving success. Arch Intern Med 2008; 168:1961-1967. This study showed that smokers with depressive symptoms measured during hospitalization for MI were less likely to quit smoking by 6-month follow-up. Referral to cardiac rehabilitation and having inpatient smoking cessation treatment predicted smoking cessation at 6 months.
15. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993; 270:1819-1825.
16. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91:999-1005.
17. Barefoot JC, Brummett BH, Helms MJ, et al. Depressive symptoms and survival of patients with coronary artery disease. Psychosom Med 2000; 62:790-795. (Pubitemid 32009085)
18. Lesperance F, Frasure-Smith N, Juneau M, Theroux P. Depression and 1-year prognosis in unstable angina. Arch Intern Med 2000; 160:1354-1360. (Pubitemid 30252784)
19. Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002; 105:1049-1053. (Pubitemid 34212612)
20. Ruo B, Rumsfeld JS, Hlatky MA, et al. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA 2003; 290:215-221. (Pubitemid 37430060)
21. Thombs BD, Bass EB, Ford DE, et al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 2006; 21:30-38.
22. Glassman AH, Stetner F, Walsh BT, et al. Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. JAMA 1988; 259:2863-2866.
23. Glassman AH, Helzer JE, Covey LS, et al. Smoking, smoking cessation, and major depression. JAMA 1990; 264:1546-1549.
24. Anda RF, Williamson DF, Escobedo LG, et al. Depression and the dynamics of smoking. A national perspective. JAMA 1990; 264:1541-1545.
25. Covey LS, Glassman AH, Stetner F. Depression and depressive symptoms in smoking cessation. Compr Psychiatry 1990; 31:350-354. (Pubitemid 20333849)
26. Cinciripini PM, Wetter DW, Fouladi RT, et al. The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy. J Consult Clin Psychol 2003; 71:292-301.
27. Berlin I, Covey L. Precessation depressive mood predicts failure to quit smoking: the role of coping and personality traits. Addiction 2006; 101:1814-1821. (Pubitemid 44899704)
28. Thomson CC, Rigotti NA. Hospital- and clinic-based smoking cessation interventions for smokers with cardiovascular disease. Prog Cardiovasc Dis 2003; 45:459-479. (Pubitemid 36666453)
29. Rigotti NA, Munafo MR, Stead LF. Smoking cessation interventions for hospitalized smokers: a systemic review. Arch Intern Med 2008; 168:1950-1960. A systematic review of studies extracted from the Cochrane Tobacco Addiction Review Group's register of trials to determine effectiveness of smoking cessation interventions initiated during hospitalization. A subgroup analysis of 18 studies that included only smokers with a cardiovascular diagnosis was performed.
30. Mohiuddin SM, Mooss AN, Hunter CB, et al. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest 2007; 131:446-452. (Pubitemid 46280405)
31. Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease. Nicotine replacement therapy for patients with coronary artery disease. Arch Intern Med 1994; 154:989-995. (Pubitemid 24144874)
32. Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996; 335:1792-1798.
33. Tzivoni D, Keren A, Meyler S, et al. Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking. Cardiovasc Drugs Ther 1998; 12:239-244. (Pubitemid 28416489)
34. Campbell IA, Prescott RJ, Tjeder-Burton SM. Transdermal nicotine plus support in patients attending hospital with smoking-related diseases: a placebo-controlled study. Respir Med 1996; 90:47-51.
35. Tonstad S, Farsang C, Klaene G, et al. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomized study. Eur Heart J 2003; 24:946-955. (Pubitemid 36559988)
36. Rigotti NA, Thorndike AN, Regan SR, et al. Bupropion for smokers hospitalized with acute cardiovascular disease. Am J Med 2006; 119:1080-1087. (Pubitemid 44834365)
37. Rigotti NA, Pipe A, Garza D, et al. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease [abstract]. J Am Coll Cardiol 2009; 53 (Suppl 1):A224.
38. Schroeder SA. A 51-year-old woman with bipolar disorder who wants to quit smoking. JAMA 2009; 301:522-531. An excellent review of treating smoking in patients with mental illness.
39. Benowitz NL. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther 2008; 83:531-541.
40. Fowler JS, Volkow ND, Wang GJ, et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature 1996; 379:733-736. (Pubitemid 26061736)
41. Fowler JS, Wang GJ, Volkow ND, et al. Maintenance of brain monoamine oxidase B inhibition in smokers after overnight cigarette abstinence. Am J Psychiatry 2000; 157:1864-1866.
42. Paperwalla KN, Levin TT, Weiner J, et al. Smoking and depression. Med Clin N Am 2004; 88:1483-1494.
43. Glassman AH, Covey LS, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. Lancet 2001; 357:1929-1932. (Pubitemid 32568334)
44. Niaura R, Britt DM, Shadel WG, et al. Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav 2001; 15:13-17. (Pubitemid 32194935)
45. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007:CD000031.
46. Brown RA, Kahler CW, Niaura R, et al. Cognitive-behavioral treatment for depression in smoking cessation. J Consult Clin Psychol 2001; 69:471-480. (Pubitemid 32667029)
47. Krishnan KRR, Delong M, Kraemer H, et al. Comorbidity of depression with other medical diseases in the elderly. Biol Psychiatry 2002; 52:559-588. (Pubitemid 35284022)
48. Davidson KW, Kupfer DJ, Bigger T, et al. Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group report. Psychosom Med 2006; 68:645-650.
49. Dimatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160:2101-2107.
50. Ziegelstein RC. Depression in patients recovering from a myocardial infarction. JAMA 2001; 286:1621-1627. (Pubitemid 33010287)
51. Kronish IM, Rieckmann N, Halm EA, et al. Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes. J Gen Intern Med 2006; 21:1178-1183. (Pubitemid 44506872)
52. Joynt KE, Whellan DJ, O'Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry 2003; 54:248-261. (Pubitemid 37267855)
53. Whooley MA, de Jonge P, Vittinghoff E, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008; 300:2379-2388. A prospective cohort study of 1017 outpatients with stable coronary heart disease. Higher rates of cardiovascular events in patients with depressive symptoms were mediated by behavioral factors, including physical inactivity and smoking.
54. Trockel M, Burg M, Jaffe A, et al. Smoking behavior postmyocardial infarction among ENRICHD trial participants: cognitive behavioral therapy intervention for depression and low perceived social support compared with care as usual. Psychosom Med 2008; 70:875-882. The only study to look at treatment of smoking in depressed patients with acute cardiovascular disease. Secondary analysis of data from the ENRICHD trial examined the effect of CBT for depression on smoking cessation rates.
55. Meine TJ, Patel MR, Washam JB, et al. Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. Am J Cardiol 2005; 95:976-978.
56. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on the Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110:e82-e293.